Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H16N2O2.ClH |
Molecular Weight | 280.75 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN1C=CN=C1CC2COC3=CC=CC=C3O2
InChI
InChIKey=ANDJPJNFVJXEKX-UHFFFAOYSA-N
InChI=1S/C14H16N2O2.ClH/c1-2-16-8-7-15-14(16)9-11-10-17-12-5-3-4-6-13(12)18-11;/h3-8,11H,2,9-10H2,1H3;1H
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20446913
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20446913
Imiloxan is a highly selective alpha2B adrenoceptor antagonist and was developed for depression in the 1980s. In Phase 1 clinical trials imiloxan dosing led to hypersensitivity reactions; the molecule's development was discontinued.
Originator
Sources: http://adisinsight.springer.com/drugs/800007859
Curator's Comment: # Roche Bioscience - UCB
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P18089 Gene ID: 151.0 Gene Symbol: ADRA2B Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1970500 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist. | 1990 Mar |
|
Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit. | 1993 Jul |
|
Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs. | 2001 Jul |
|
The role of several alpha(1)- and alpha(2)-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation. | 2001 Mar |
|
Antinociceptive synergism of MD-354 and clonidine. Part II. The alpha-adrenoceptor component. | 2010 Aug |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1352928
Single dose - 500 mg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1970500
Curator's Comment: Imiloxan was identified as a selective alpha 2B ligand of the adrenoceptor
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Fri Dec 15 16:30:48 GMT 2023 , Edited by admin on Fri Dec 15 16:30:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
X72FO6ZLZY
Created by
admin on Fri Dec 15 16:30:48 GMT 2023 , Edited by admin on Fri Dec 15 16:30:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL347695
Created by
admin on Fri Dec 15 16:30:48 GMT 2023 , Edited by admin on Fri Dec 15 16:30:48 GMT 2023
|
PRIMARY | |||
|
86710-23-8
Created by
admin on Fri Dec 15 16:30:48 GMT 2023 , Edited by admin on Fri Dec 15 16:30:48 GMT 2023
|
PRIMARY | |||
|
W-2
Created by
admin on Fri Dec 15 16:30:48 GMT 2023 , Edited by admin on Fri Dec 15 16:30:48 GMT 2023
|
PRIMARY | |||
|
172975
Created by
admin on Fri Dec 15 16:30:48 GMT 2023 , Edited by admin on Fri Dec 15 16:30:48 GMT 2023
|
PRIMARY | |||
|
C83793
Created by
admin on Fri Dec 15 16:30:48 GMT 2023 , Edited by admin on Fri Dec 15 16:30:48 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD